Tretinoin NDC 68071-3865

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-3865Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-3865Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-3865-2	68071386502	1 TUBE in 1 CARTON (68071-3865-2) / 20 g in 1 TUBEMarketed from Jun 10, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tretinoin
Generic name (nonproprietary): tretinoin
Active ingredients: Tretinoin — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211644
Marketing start: Jan 25, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 68071-3865_373dda8f-0dcc-4554-e063-6394a90ad5ebSPL ID 373dda8f-0dcc-4554-e063-6394a90ad5ebSPL set ID 373dd14d-061a-4408-e063-6394a90abf95RxCUI 106303UNII 5688UTC01RUPC 0368071386523
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071386502 followed by a unit qualifier and the quantity

Package 68071-3865-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 10, 2025.

Indications (excerpt from the label)

Indications and Usage Tretinoin cream is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211644

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211644
Product	Strength	Form · route	Labeler	Product NDC
Tretinoin	Tretinoin .5 mg/g	CreamTopical	A-S Medication Solutions	50090-6819
Tretinoin	Tretinoin .5 mg/g	CreamTopical	NORTHSTAR RX LLC	16714-249
Tretinoin	Tretinoin .5 mg/g	CreamTopical	Sun Pharmaceutical Industries, Inc.	51672-1394